Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferase

内科学 脂肪性肝炎 医学 胃肠病学 脂肪肝 肝损伤 代谢综合征 疾病 肥胖
作者
Andrew S. Lim,Sheena N. Cruz,Aliya Asghar Uddin,Olga Malysheva,Marie A. Caudill,Cristina Alonso,Alejandro Montilla,M.A. Karsdal,Diana Julie Leeming,Alejandro E. Mayorca‐Guiliani,Frederik Høbjerg Svejsø,Craig James McClain,Timothy R.M. Morgan
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:83 (6): 1515-1528 被引量:13
标识
DOI:10.1097/hep.0000000000001477
摘要

BACKGROUND AND AIMS: Betaine, 20 g/day for 12 months, reduced liver injury in several trials in non-alcoholic steatohepatitis (NASH). Our aim was to determine the safety and efficacy of lower doses of betaine in clinically diagnosed metabolic dysfunction-associated steatotic liver disease (MASLD) and an elevated ALT. APPROACH AND RESULTS: We performed 3 pilot trials in participants with clinically diagnosed non-cirrhotic MASLD and ALT ≥50 U/L. In the first trial, 44 participants were randomized to 4 or 8 g daily for 12 weeks. In the second trial, 10 participants received 1 g/day for 24 weeks, while 16 participants received 2 g/day for 24 weeks in the third trial. The primary outcome was the percent decline in the abnormal component of ALT (ie, ALT >30 for males or >25 for females). Other outcomes included improvement in absolute ALT and AST, and other serologic tests of liver injury, including metabolomics-advanced steatohepatitis fibrosis (MASEF) score, cytokeratin 18, and pro-C3. Baseline and end-of-treatment data were compared with a paired t test. At baseline, more than 75% of participants had NASH when tested by the MASEF score. ALT, AST, cytokeratin 18, pro-C3, and MASEF score decreased significantly among participants receiving 8, 4​​​​​, and 2 g, but not 1 g. High-density lipoprotein increased in the 4 and 2 g cohorts; low-density lipoprotein did not change. Approximately 35% reported mild, transient gastrointestinal symptoms. CONCLUSIONS: Betaine 8, 4​​​​​​, and 2 g/day for 12-24 weeks significantly reduced ALT and other serologic markers of liver injury among participants with clinically defined MASLD and an elevated ALT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被赤壁采纳,获得10
刚刚
Edward完成签到,获得积分10
刚刚
Jun的应助被高兴白山采纳,获得10
刚刚
黃偉倫的应助被学术顺利采纳,获得10
刚刚
桔zi完成签到,获得积分10
刚刚
落后钢铁侠完成签到 ,获得积分10
1秒前
成就钧完成签到,获得积分10
1秒前
虚心的咖啡豆完成签到,获得积分10
1秒前
Shireen完成签到,获得积分10
1秒前
张凯文完成签到,获得积分10
1秒前
2秒前
呋喃完成签到,获得积分10
2秒前
dddj发布了新的文献求助10
2秒前
吉伊拯救世界完成签到 ,获得积分10
2秒前
3秒前
3秒前
优秀q发布了新的文献求助10
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
Code_king发布了新的文献求助10
4秒前
4秒前
4秒前
small_LL发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
5秒前
5秒前
5秒前
5秒前
linxiansheng完成签到,获得积分10
5秒前
5秒前
5秒前
丘比特的应助被yang采纳,获得10
5秒前
6秒前
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176287
求助须知:如何正确求助?哪些是违规求助? 9567719
关于积分的说明 21794359
捐赠科研通 7771008
什么是DOI,文献DOI怎么找? 3431998
关于科研通互助平台的介绍 2556315
邀请新用户注册赠送积分活动 2477650